title: [Intensive care for emerging infectious diseases--Ebola and Dengue].
abstract: Although significant effort has been made for the development of treatment and prevention of Ebola hemorrhagic fever, one has to keep in mind that basic supportive therapy, including sufficient hydration to the patients, would be a standard of care for Ebola hemorrhagic fever and other antiviral therapy would be an adjunct to this standard of care. Also, effective antiviral drug to dengue virus is not known, and a basic supportive therapy, including fluid therapy, would be a standard of care and prevent serious type of dengue virus infections. Aspirin and other non-steroidal anti-inflammatory drug must not be used, because they promote bleeding and acidosis.
authors.forename: Norio
authors.initials: N
authors.lastname: Ohmagari
mesh_terms: D058109:Airway Management; D000553:Ambulatory Care; D021821:Communicable Diseases, Emerging; D003422:Critical Care / Q000379:methods; D003715:Dengue / Q000517:prevention & control / Q000628:therapy*; D004573:Electrolytes / Q000008:administration & dosage; D005440:Fluid Therapy / Q000379:methods; D019142:Hemorrhagic Fever, Ebola / Q000517:prevention & control / Q000628:therapy*; D006760:Hospitalization; D006801:Humans; D008991:Monitoring, Physiologic; D006435:Renal Dialysis; D055986:Vital Signs; D014882:Water-Electrolyte Balance
chemical_list: D004573:Electrolytes